Unternehmen
MILTENYI BIOTEC BV & CO KG
MILTENYI BIOTEC BV & CO KG – Unternehmen mit Aktivitäten in Forschung und Innovation.
Weiter entdecken
Ähnliche Beiträge
Unternehmen
→
MILTENYI BIOTEC GMBH
MILTENYI BIOTEC GMBH – Unternehmen mit Aktivitäten in Forschung und Innovation. Beitrag ansehen →
Projekt
→
Artificial intelligence for synthetic functional genomics of blood
Our abilities to predict and engineer complex biological systems are in their infancy. In the context of gene regulation, we cann… Beitrag ansehen →
Unternehmen
→
PROMOVE-BIOTEC GMBH
Beitrag ansehen →
Passend zu diesem Beitrag
Forschungsprojekte
- FINE-TUNING T CELL NETWORKS OF EXHAUSTION BY SYNTHETIC SENSORS Cell and gene therapies offer a massive paradigm shift from current treatment options and hold the potential… →
- Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment Isocitrate dehydrogenase wildtype (IDHwt) glioblastoma (GBM) is the most frequent, aggressive and lethal brai… →
- Gene Therapy of Rare Diseases More than 300 million people worldwide are suffering from more than 6000 rare diseases. Nearly all of these r… →
- Future of ALCL: Novel Therapies, Origins, Bio-Markers and Mechanism of resistance The FANTOM Doctoral Network (DN) composed of 7 beneficiaries and 12 associated partners in 5 EU countries, re… →
- Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers CarrerasLeaders is a new innovative and international postdoctoral programme, designed by Josep Carreras Leuk… →
- Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe) Type 1 diabetes (T1D) is an incurable disease, often starting in childhood, with a risk of devastating compli… →